ID-45 Tablet is used in the treatment of Friedreich's ataxia and leber’s hereditary optic neuropathy.
ID-45 Tablet side effects
Side Effects of ID-45 are Nasopharyngitis (inflammation of the throat and nasal passages), Cough, Diarrhoea, Back pain.
How to use ID-45 Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. ID-45 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Idebenone belongs to the class of drugs called as antioxidants (a molecule that prevents oxidation of another molecule). It acts by protecting wide variety of cells from oxidative damage thereby increasing production of energy by cells.
In Depth Information on ID-45 Tablet
Expert advice for ID-45 Tablet
You will be regularly monitored to check complete blood count and liver function test values while on idebenone treatment.
Inform your doctor in case you have mild kidney impairment.
Inform your doctor if you are an elderly patient.
Exercise caution before using idebenone in children <8 years.
Do not take if allergic to idebenone or any of its ingredients.
Do not take if suffering from moderate or severe hepatic or renal impairment.
Do not take if Pregnant or breastfeeding women.
ID-45 Tablet related warnings
Special precautions for ID-45 Tablet
Interaction with alcohol is unknown. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of ID-45 Tablet during lactation. Please consult your doctor.
ID-45 Tablet does not usually affect your ability to drive.
There is limited information available on the use of ID-45 Tablet in patients with kidney disease. Please consult your doctor. However, a cautious use of this medicine is advised in these patients.
There is limited information available on the use of ID-45 Tablet in patients with liver disease. Please consult your doctor. However, a cautious use of this medicine is advised in these patients.